HomeProductsBioactive CompoundsMetabolic EnzymesVD/VDRParicalcitol
Chemical structure of CAS 131918-61-1

Paricalcitol

CAS No.131918-61-1
MDL No.MFCD08067734
MFC27H44O3
MW416.60
InChI KeyBPKAHTKRCLCHEA-UBFJEZKGSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Paricalcitol is a hydroxy seco-cholestane and a vitamin D2 analog with antiparathyroid activity.

CAS No.131918-61-1
Product NameParicalcitol
Heavy Atom Count30Rotatable Bond Count5
Atom Stereo Count7Bond Stereo Count2
HBA3HBD3
TPSA60.690 ŲCharge0
Exact Mass416.32905Complexity670.71
pKa7.765XLogP5.561

Related Articles

Studies related to this compound and its mechanism of action

Differential effects of vitamin D analogs on vascular calcification.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • Vol. 22, Issue 6 • 2007
PMID: 17352647DOI: 10.1359/jbmr.070305

Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols.

Calcified tissue international • Vol. 79, Issue 6 • 2006
PMID: 17171500DOI: 10.1007/s00223-006-0126-z

19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro.

Molecular pharmacology • Vol. 69, Issue 5 • 2006
PMID: 16484501DOI: 10.1124/mol.105.019851

19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.

Cancer research • Vol. 65, Issue 6 • 2005
PMID: 15781666DOI: 10.1158/0008-5472.CAN-04-2800

Documentation

Similar Products